p25/Cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons

Journal of Neurochemistry

Volumn 102, Issue 1, 2007, Pages 133-140

  Saito, Taro ^a   Konno, Tsunetada ^a   Hosokawa, Tomohisa ^a   Asada, Akiko ^a   Ishiguro, Koichi ^b   Hisanaga, Shin Ichi ^a  

^a TOKYO METROPOLITAN UNIVERSITY   (Japan)

^b MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

Author keywords

Calpain; Cyclin dependent kinase 5; Endoplasmic reticulum stress; Neurodegenerative disease; Neuronal cell death; Nuclear translocation

Indexed keywords

CALPAIN; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P25; PROTEIN P35;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; NUCLEAR IMPORT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALS; BLOTTING, WESTERN; CALPAIN; CELL DEATH; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; ENDOPLASMIC RETICULUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; NERVE TISSUE PROTEINS; NEURONS; PREGNANCY; PROTEIN KINASES; RATS; TRANSLOCATION, GENETIC;

EID: 34250200796     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04540.x     Document Type: Article

References (42)

1. Becker E. B. Bonni A. (2004) Cell cycle regulation of neuronal apoptosis in development and disease. Prog. Neurobiol. 72, 1 25.
2. Cruz J. C., Tseng H. C., Goldman J. A., Shih H. Tsai L. H. (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 30, 471 483.
3. Dhavan R. Tsai L. H. (2001) A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2, 749 759.
4. Forman M. S., Lee V. M. Trojanowski J. Q. (2003) 'Unfolding' pathways in neurodegenerative disease. Trends Neurosci. 26, 407 410.
5. Gong X., Tang X., Wiedmann M., Wang X., Peng J., Zheng D., Blair L. A., Marshall J. Mao Z. (2003) Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38, 33 46.
6. Hashiguchi M., Saito T., Hisanaga S. Hashiguchi T. (2002) Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau. J. Biol. Chem. 277, 44 525 44 530.
7. Hisanaga S. Saito T. (2003) The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Neurosignals 12, 221 229.
8. Hisanaga S., Uchiyama M., Hosoi T., Yamada K., Honma N., Ishiguro K., Uchida T., Dahl D., Ohsumi K. Kishimoto T. (1995) Porcine brain neurofilament-H tail domain kinase: its identification as cdk5/p26 complex and comparison with cdc2/cyclin B kinase. Cell Motil. Cytoskeleton. 31, 283 297.
9. Hitomi J., Katayama T., Taniguchi M., Honda A., Imaizumi K. Tohyama M. (2004) Apoptosis induced by endoplasmic reticulum stress depends on activation of caspase-3 via caspase-12. Neurosci. Lett. 357, 127 130.
10. Ino H. Chiba T. (1996) Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm. Brain Res. 732, 179 185.
11. Ishiguro K., Sato K., Takamatsu M., Park J., Uchida T. Imahori K. (1995) Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites. Neurosci. Lett. 202, 81 84.
12. Katayama T., Imaizumi K., Sato N. et al. (1999) Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat. Cell Biol. 8, 479 485.
13. Kaufman R. J. (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13, 1211 1233.
14. Kerokoski P., Suuronen T., Salminen A., Soininen H. Pirttila T. (2002) Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation. Biochem. Biophys. Res. Commun. 298, 693 698.
15. Kusakawa G., Saito T., Onuki R., Ishiguro K., Kishimoto T. Hisanaga S. (2000) Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 275, 17 166 17 172.
16. Lee A. S. (1992) Mammalian stress response: induction of the glucose-regulated protein family. Curr. Opin. Cell Biol. 4, 267 273.
17. Lee K. Y., Helbing C. C., Choi K. S., Johnston R. N. Wang J. H. (1997) Neuronal Cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein. J. Biol. Chem. 272, 5622 5626.
18. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M. Tsai L. H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360 364.
19. Moncada S. Bolanos J. P. (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J. Neurochem. 97, 1676 1689.
20. Mori K. (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101, 451 454.
21. Nakagawa T. Yuan J. (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150, 887 894.
22. Nigg E. A. (1995) Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17, 471 480.
23. Nikolic M., Dudek H., Kwon Y. T., Ramos Y. F. Tsai L. H. (1996) The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816 825.
24. Noble W., Olm V., Takata K. et al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38, 555 565.
25. O'Hare M. J., Kushwaha N., Zhang Y., Aleyasin H., Callaghan S. M., Slack R. S., Albert P. R., Vincent I. Park D. S. (2005) Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J. Neurosci. 25, 8954 8966.
26. Onuki R., Bando Y., Suyama E., Katayama T., Kawasaki H., Baba T., Tohyama M. Taira K. (2004) An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J. 23, 959 968.
27. Paglini G., Peris L., Diez-Guerra J., Quiroga S. Caceres A. (2001) The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic. EMBO Rep. 2, 1139 1144.
28. Patrick G. N., Zhou P., Kwon Y. T., Howley P. M. Tsai L. H. (1998) p35, the neuronal-specific activator of cyclin-dependant kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J. Biol. Chem. 273, 24057 24064.
29. Patrick G. N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P. Tsai L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615 622.
30. Rutkowski D. T. Kaufman R. J. (2004) A trip to the ER: coping with stress. Trends Cell Biol. 14, 20 28.
31. Sai X., Kawamura Y., Kokame K. et al. (2002) Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J. Biol. Chem. 277, 12 915 12 920.
32. Saito T., Ishiguro K., Onuki R., Nagai Y., Kishimoto T. Hisanaga S. (1998) Okadaic acid stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons. Biochem. Biophys. Res. Commun. 252, 775 778.
33. Saito T., Onuki R., Fujita Y., Kusakawa G., Ishiguro K., Bibb J. A., Kishimoto T. Hisanaga S. (2003) Developmental regulation of the proteolysis of the p35 Cyclin-Dependent Kinase 5 Activator by Phosphorylation. J. Neurosci. 23, 1189 1197.
34. Sakaue F., Saito T., Sato Y., Asada A., Ishiguro K., Hasegawa M. Hisanaga S. (2005) Phosphorylation of FTDP-17 mutant TAU by cyclin-dependent kinase 5 complexed with p35, p25, or p39. J. Biol. Chem. 280, 31 522 31 529.
35. Shelton S. B., Krishnamurthy P. Johnson G. V. (2004) Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells. J. Neurosci. Res. 76, 110 120.
36. Siman R., Flood D. G., Thinakaran G. Neumar R. W. (2001) Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer's disease-linked presenilin-1 knock-in mutation. J. Biol. Chem. 276, 44 736 44 743.
37. Takashima A., Murayama M., Yasutake K., Takahashi H., Yokoyama M. Ishiguro K. (2001) Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain. Neurosci. Lett. 306, 37 40.
38. Taniguchi S., Fujita Y., Hayashi S., Kakita A., Takahashi H., Murayama S., Saido T. C., Hisanaga S., Iwatsubo T. Hasegawa M. (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett 489, 46 50.
39. Tseng H. C., Zhou Y., Shen Y. Tsai L. H. (2002) A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett. 523, 58 62.
40. Uchida T., Ishiguro K., Ohnuma J., Takamatsu M., Yonekura S. Imahori K. (1994) Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: its sequence and developmental change in brain. FEBS Lett. 355, 35 40.
41. Yoo B. C. Lubec G. (2001) p25 protein in neurodegeneration. Nature 411, 763 764.
42. Zhang J., Krishnamurthy P. K. Johnson G. V. (2002) Cdk5 phosphorylates p53 and regulates its activity. J. Neurochem. 81, 307 313.